Cabaletta Bio, Inc. (CABA)

NASDAQ

$1.57

$-0.13

(-7.40%)

Regular Market

Cabaletta Bio, Inc. (CABA) Live Price Chart

Last updated: ⁦2026-10-14 16:54:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Cabaletta Bio, Inc. (CABA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $1.57, with a market capitalisation of $303.49M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.56 to $4.23. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$303.49M
Open	$1.64
Day's High	$26.35
Day's Low	$0.59
Previous Close	$1.69
Volume	2.49M
Average Volume	4.71M
P/E Ratio	--
52-Week High	$4.23
52-Week Low	$1.56
Dividend Yield	--
Earnings Date	--

Cabaletta Bio, Inc. (CABA) Stock Price Today

Cabaletta Bio, Inc. (CABA) is currently trading at $1.57 as of 2026-10-14 16:53:00, down 7.40% ($0.13) from the previous close of $1.69

During today's regular trading session, CABA has traded between $0.59 and $26.35, with a trading volume of 2.49M shares. The current price is near the lower end of today's range.

Cabaletta Bio, Inc. (CABA) 7-Day Stock Price Change

Over the past seven days, Cabaletta Bio, Inc. (CABA) moved from $2.08 to $1.57, representing a decline of 24.76% ($0.52).

The stock traded between $1.56 and $2.14 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 4.71 million shares, down versus the previous seven-day period, indicating lower trading activity.

CABA 52-Week Price Position

Position in Range: 0.4%

52W Low$1.56

52W High$4.23

CABA is currently trading at $1.57, placing it 0.4% of the way from its 52-week low of $1.56 to its 52-week high of $4.23. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Cabaletta Bio, Inc. (CABA)?

Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA approach, which uses chimeric antigen receptor T cells to eliminate B cells and potentially reset the immune system. The company develops cellular therapies including CAR T and CAAR T product candidates. Its candidate, rese-cel (resecabtagene autoleucel), a CD19-CAR T cell therapy, is being evaluated in Phase 1/2 trials for autoimmune diseases such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris.

Cabaletta Bio, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	158
Exchange	NASDAQ
Company Website	https://www.cabalettabio.com

How to Buy Cabaletta Bio, Inc. (CABA) Stock on MEXC

Eligible investors can buy real shares of Cabaletta Bio, Inc. (CABA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CABA and Place Your Order

Open the RealStocks trading page and search for CABA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Cabaletta Bio, Inc. (CABA) stock price today?

Cabaletta Bio, Inc. (CABA) is currently trading at $ 1.57, down 7.40% ($0.13) from the previous close of $ 1.69. Intraday prices update in real time during regular trading hours.

2.Is CABA stock going up or down today?

As of 2026-10-14 16:53:00, CABA is trading at $ 1.57, down 7.40% ($0.13) from its previous close of $ 1.69. The stock has traded between $ 0.59 and $ 26.35 during today’s regular session. Past price movements do not guarantee future results.

3.What is CABA pre-market price?

As of 2026-10-14 16:53:00, CABA is trading at $ 1.64 in pre-market trading, down 3.02% ($0.05) from the previous close of $ 1.69. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CABA after-hours price?

As of 2026-10-14 16:53:00, CABA is trading at $ 1.68 in after-hours trading, down 0.89% ($0.01) from the regular-session close of $ 1.69. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CABA stock trading now?

CABA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CABA sit relative to its 52-week high and low?

Over the past 52 weeks, CABA has traded between a low of $ 1.56 and a high of $ 4.23. At $ 1.57, the stock is positioned 0.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Cabaletta Bio, Inc. in?

Cabaletta Bio, Inc. (CABA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Cabaletta Bio, Inc.'s market capitalisation and where is it listed?

Cabaletta Bio, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 303.49M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CABA valued in terms of P/E ratio and EPS?

CABA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.07. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Cabaletta Bio, Inc. pay a dividend?

Cabaletta Bio, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.